Cargando…
Fatty acids in the de novo lipogenesis pathway and incidence of type 2 diabetes: A pooled analysis of prospective cohort studies
BACKGROUND: De novo lipogenesis (DNL) is the primary metabolic pathway synthesizing fatty acids from carbohydrates, protein, or alcohol. Our aim was to examine associations of in vivo levels of selected fatty acids (16:0, 16:1n7, 18:0, 18:1n9) in DNL with incidence of type 2 diabetes (T2D). METHODS...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7292352/ https://www.ncbi.nlm.nih.gov/pubmed/32530938 http://dx.doi.org/10.1371/journal.pmed.1003102 |
_version_ | 1783546094645411840 |
---|---|
author | Imamura, Fumiaki Fretts, Amanda M. Marklund, Matti Ardisson Korat, Andres V. Yang, Wei-Sin Lankinen, Maria Qureshi, Waqas Helmer, Catherine Chen, Tzu-An Virtanen, Jyrki K. Wong, Kerry Bassett, Julie K. Murphy, Rachel Tintle, Nathan Yu, Chaoyu Ian Brouwer, Ingeborg A. Chien, Kuo-Liong Chen, Yun-yu Wood, Alexis C. del Gobbo, Liana C. Djousse, Luc Geleijnse, Johanna M. Giles, Graham G. de Goede, Janette Gudnason, Vilmundur Harris, William S. Hodge, Allison Hu, Frank Koulman, Albert Laakso, Markku Lind, Lars Lin, Hung-Ju McKnight, Barbara Rajaobelina, Kalina Riserus, Ulf Robinson, Jennifer G. Samieri, Cecilia Senn, Mackenzie Siscovick, David S. Soedamah-Muthu, Sabita S. Sotoodehnia, Nona Sun, Qi Tsai, Michael Y. Tuomainen, Tomi-Pekka Uusitupa, Matti Wagenknecht, Lynne E. Wareham, Nick J. Wu, Jason H. Y. Micha, Renata Lemaitre, Rozenn N. Mozaffarian, Dariush Forouhi, Nita G. |
author_facet | Imamura, Fumiaki Fretts, Amanda M. Marklund, Matti Ardisson Korat, Andres V. Yang, Wei-Sin Lankinen, Maria Qureshi, Waqas Helmer, Catherine Chen, Tzu-An Virtanen, Jyrki K. Wong, Kerry Bassett, Julie K. Murphy, Rachel Tintle, Nathan Yu, Chaoyu Ian Brouwer, Ingeborg A. Chien, Kuo-Liong Chen, Yun-yu Wood, Alexis C. del Gobbo, Liana C. Djousse, Luc Geleijnse, Johanna M. Giles, Graham G. de Goede, Janette Gudnason, Vilmundur Harris, William S. Hodge, Allison Hu, Frank Koulman, Albert Laakso, Markku Lind, Lars Lin, Hung-Ju McKnight, Barbara Rajaobelina, Kalina Riserus, Ulf Robinson, Jennifer G. Samieri, Cecilia Senn, Mackenzie Siscovick, David S. Soedamah-Muthu, Sabita S. Sotoodehnia, Nona Sun, Qi Tsai, Michael Y. Tuomainen, Tomi-Pekka Uusitupa, Matti Wagenknecht, Lynne E. Wareham, Nick J. Wu, Jason H. Y. Micha, Renata Lemaitre, Rozenn N. Mozaffarian, Dariush Forouhi, Nita G. |
author_sort | Imamura, Fumiaki |
collection | PubMed |
description | BACKGROUND: De novo lipogenesis (DNL) is the primary metabolic pathway synthesizing fatty acids from carbohydrates, protein, or alcohol. Our aim was to examine associations of in vivo levels of selected fatty acids (16:0, 16:1n7, 18:0, 18:1n9) in DNL with incidence of type 2 diabetes (T2D). METHODS AND FINDINGS: Seventeen cohorts from 12 countries (7 from Europe, 7 from the United States, 1 from Australia, 1 from Taiwan; baseline years = 1970–1973 to 2006–2010) conducted harmonized individual-level analyses of associations of DNL-related fatty acids with incident T2D. In total, we evaluated 65,225 participants (mean ages = 52.3–75.5 years; % women = 20.4%–62.3% in 12 cohorts recruiting both sexes) and 15,383 incident cases of T2D over the 9-year follow-up on average. Cohort-specific association of each of 16:0, 16:1n7, 18:0, and 18:1n9 with incident T2D was estimated, adjusted for demographic factors, socioeconomic characteristics, alcohol, smoking, physical activity, dyslipidemia, hypertension, menopausal status, and adiposity. Cohort-specific associations were meta-analyzed with an inverse-variance-weighted approach. Each of the 4 fatty acids positively related to incident T2D. Relative risks (RRs) per cohort-specific range between midpoints of the top and bottom quintiles of fatty acid concentrations were 1.53 (1.41–1.66; p < 0.001) for 16:0, 1.40 (1.33–1.48; p < 0.001) for 16:1n-7, 1.14 (1.05–1.22; p = 0.001) for 18:0, and 1.16 (1.07–1.25; p < 0.001) for 18:1n9. Heterogeneity was seen across cohorts (I(2) = 51.1%–73.1% for each fatty acid) but not explained by lipid fractions and global geographical regions. Further adjusted for triglycerides (and 16:0 when appropriate) to evaluate associations independent of overall DNL, the associations remained significant for 16:0, 16:1n7, and 18:0 but were attenuated for 18:1n9 (RR = 1.03, 95% confidence interval (CI) = 0.94–1.13). These findings had limitations in potential reverse causation and residual confounding by imprecisely measured or unmeasured factors. CONCLUSIONS: Concentrations of fatty acids in the DNL were positively associated with T2D incidence. Our findings support further work to investigate a possible role of DNL and individual fatty acids in the development of T2D. |
format | Online Article Text |
id | pubmed-7292352 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-72923522020-06-18 Fatty acids in the de novo lipogenesis pathway and incidence of type 2 diabetes: A pooled analysis of prospective cohort studies Imamura, Fumiaki Fretts, Amanda M. Marklund, Matti Ardisson Korat, Andres V. Yang, Wei-Sin Lankinen, Maria Qureshi, Waqas Helmer, Catherine Chen, Tzu-An Virtanen, Jyrki K. Wong, Kerry Bassett, Julie K. Murphy, Rachel Tintle, Nathan Yu, Chaoyu Ian Brouwer, Ingeborg A. Chien, Kuo-Liong Chen, Yun-yu Wood, Alexis C. del Gobbo, Liana C. Djousse, Luc Geleijnse, Johanna M. Giles, Graham G. de Goede, Janette Gudnason, Vilmundur Harris, William S. Hodge, Allison Hu, Frank Koulman, Albert Laakso, Markku Lind, Lars Lin, Hung-Ju McKnight, Barbara Rajaobelina, Kalina Riserus, Ulf Robinson, Jennifer G. Samieri, Cecilia Senn, Mackenzie Siscovick, David S. Soedamah-Muthu, Sabita S. Sotoodehnia, Nona Sun, Qi Tsai, Michael Y. Tuomainen, Tomi-Pekka Uusitupa, Matti Wagenknecht, Lynne E. Wareham, Nick J. Wu, Jason H. Y. Micha, Renata Lemaitre, Rozenn N. Mozaffarian, Dariush Forouhi, Nita G. PLoS Med Research Article BACKGROUND: De novo lipogenesis (DNL) is the primary metabolic pathway synthesizing fatty acids from carbohydrates, protein, or alcohol. Our aim was to examine associations of in vivo levels of selected fatty acids (16:0, 16:1n7, 18:0, 18:1n9) in DNL with incidence of type 2 diabetes (T2D). METHODS AND FINDINGS: Seventeen cohorts from 12 countries (7 from Europe, 7 from the United States, 1 from Australia, 1 from Taiwan; baseline years = 1970–1973 to 2006–2010) conducted harmonized individual-level analyses of associations of DNL-related fatty acids with incident T2D. In total, we evaluated 65,225 participants (mean ages = 52.3–75.5 years; % women = 20.4%–62.3% in 12 cohorts recruiting both sexes) and 15,383 incident cases of T2D over the 9-year follow-up on average. Cohort-specific association of each of 16:0, 16:1n7, 18:0, and 18:1n9 with incident T2D was estimated, adjusted for demographic factors, socioeconomic characteristics, alcohol, smoking, physical activity, dyslipidemia, hypertension, menopausal status, and adiposity. Cohort-specific associations were meta-analyzed with an inverse-variance-weighted approach. Each of the 4 fatty acids positively related to incident T2D. Relative risks (RRs) per cohort-specific range between midpoints of the top and bottom quintiles of fatty acid concentrations were 1.53 (1.41–1.66; p < 0.001) for 16:0, 1.40 (1.33–1.48; p < 0.001) for 16:1n-7, 1.14 (1.05–1.22; p = 0.001) for 18:0, and 1.16 (1.07–1.25; p < 0.001) for 18:1n9. Heterogeneity was seen across cohorts (I(2) = 51.1%–73.1% for each fatty acid) but not explained by lipid fractions and global geographical regions. Further adjusted for triglycerides (and 16:0 when appropriate) to evaluate associations independent of overall DNL, the associations remained significant for 16:0, 16:1n7, and 18:0 but were attenuated for 18:1n9 (RR = 1.03, 95% confidence interval (CI) = 0.94–1.13). These findings had limitations in potential reverse causation and residual confounding by imprecisely measured or unmeasured factors. CONCLUSIONS: Concentrations of fatty acids in the DNL were positively associated with T2D incidence. Our findings support further work to investigate a possible role of DNL and individual fatty acids in the development of T2D. Public Library of Science 2020-06-12 /pmc/articles/PMC7292352/ /pubmed/32530938 http://dx.doi.org/10.1371/journal.pmed.1003102 Text en © 2020 Imamura et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Imamura, Fumiaki Fretts, Amanda M. Marklund, Matti Ardisson Korat, Andres V. Yang, Wei-Sin Lankinen, Maria Qureshi, Waqas Helmer, Catherine Chen, Tzu-An Virtanen, Jyrki K. Wong, Kerry Bassett, Julie K. Murphy, Rachel Tintle, Nathan Yu, Chaoyu Ian Brouwer, Ingeborg A. Chien, Kuo-Liong Chen, Yun-yu Wood, Alexis C. del Gobbo, Liana C. Djousse, Luc Geleijnse, Johanna M. Giles, Graham G. de Goede, Janette Gudnason, Vilmundur Harris, William S. Hodge, Allison Hu, Frank Koulman, Albert Laakso, Markku Lind, Lars Lin, Hung-Ju McKnight, Barbara Rajaobelina, Kalina Riserus, Ulf Robinson, Jennifer G. Samieri, Cecilia Senn, Mackenzie Siscovick, David S. Soedamah-Muthu, Sabita S. Sotoodehnia, Nona Sun, Qi Tsai, Michael Y. Tuomainen, Tomi-Pekka Uusitupa, Matti Wagenknecht, Lynne E. Wareham, Nick J. Wu, Jason H. Y. Micha, Renata Lemaitre, Rozenn N. Mozaffarian, Dariush Forouhi, Nita G. Fatty acids in the de novo lipogenesis pathway and incidence of type 2 diabetes: A pooled analysis of prospective cohort studies |
title | Fatty acids in the de novo lipogenesis pathway and incidence of type 2 diabetes: A pooled analysis of prospective cohort studies |
title_full | Fatty acids in the de novo lipogenesis pathway and incidence of type 2 diabetes: A pooled analysis of prospective cohort studies |
title_fullStr | Fatty acids in the de novo lipogenesis pathway and incidence of type 2 diabetes: A pooled analysis of prospective cohort studies |
title_full_unstemmed | Fatty acids in the de novo lipogenesis pathway and incidence of type 2 diabetes: A pooled analysis of prospective cohort studies |
title_short | Fatty acids in the de novo lipogenesis pathway and incidence of type 2 diabetes: A pooled analysis of prospective cohort studies |
title_sort | fatty acids in the de novo lipogenesis pathway and incidence of type 2 diabetes: a pooled analysis of prospective cohort studies |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7292352/ https://www.ncbi.nlm.nih.gov/pubmed/32530938 http://dx.doi.org/10.1371/journal.pmed.1003102 |
work_keys_str_mv | AT imamurafumiaki fattyacidsinthedenovolipogenesispathwayandincidenceoftype2diabetesapooledanalysisofprospectivecohortstudies AT frettsamandam fattyacidsinthedenovolipogenesispathwayandincidenceoftype2diabetesapooledanalysisofprospectivecohortstudies AT marklundmatti fattyacidsinthedenovolipogenesispathwayandincidenceoftype2diabetesapooledanalysisofprospectivecohortstudies AT ardissonkoratandresv fattyacidsinthedenovolipogenesispathwayandincidenceoftype2diabetesapooledanalysisofprospectivecohortstudies AT yangweisin fattyacidsinthedenovolipogenesispathwayandincidenceoftype2diabetesapooledanalysisofprospectivecohortstudies AT lankinenmaria fattyacidsinthedenovolipogenesispathwayandincidenceoftype2diabetesapooledanalysisofprospectivecohortstudies AT qureshiwaqas fattyacidsinthedenovolipogenesispathwayandincidenceoftype2diabetesapooledanalysisofprospectivecohortstudies AT helmercatherine fattyacidsinthedenovolipogenesispathwayandincidenceoftype2diabetesapooledanalysisofprospectivecohortstudies AT chentzuan fattyacidsinthedenovolipogenesispathwayandincidenceoftype2diabetesapooledanalysisofprospectivecohortstudies AT virtanenjyrkik fattyacidsinthedenovolipogenesispathwayandincidenceoftype2diabetesapooledanalysisofprospectivecohortstudies AT wongkerry fattyacidsinthedenovolipogenesispathwayandincidenceoftype2diabetesapooledanalysisofprospectivecohortstudies AT bassettjuliek fattyacidsinthedenovolipogenesispathwayandincidenceoftype2diabetesapooledanalysisofprospectivecohortstudies AT murphyrachel fattyacidsinthedenovolipogenesispathwayandincidenceoftype2diabetesapooledanalysisofprospectivecohortstudies AT tintlenathan fattyacidsinthedenovolipogenesispathwayandincidenceoftype2diabetesapooledanalysisofprospectivecohortstudies AT yuchaoyuian fattyacidsinthedenovolipogenesispathwayandincidenceoftype2diabetesapooledanalysisofprospectivecohortstudies AT brouweringeborga fattyacidsinthedenovolipogenesispathwayandincidenceoftype2diabetesapooledanalysisofprospectivecohortstudies AT chienkuoliong fattyacidsinthedenovolipogenesispathwayandincidenceoftype2diabetesapooledanalysisofprospectivecohortstudies AT chenyunyu fattyacidsinthedenovolipogenesispathwayandincidenceoftype2diabetesapooledanalysisofprospectivecohortstudies AT woodalexisc fattyacidsinthedenovolipogenesispathwayandincidenceoftype2diabetesapooledanalysisofprospectivecohortstudies AT delgobbolianac fattyacidsinthedenovolipogenesispathwayandincidenceoftype2diabetesapooledanalysisofprospectivecohortstudies AT djousseluc fattyacidsinthedenovolipogenesispathwayandincidenceoftype2diabetesapooledanalysisofprospectivecohortstudies AT geleijnsejohannam fattyacidsinthedenovolipogenesispathwayandincidenceoftype2diabetesapooledanalysisofprospectivecohortstudies AT gilesgrahamg fattyacidsinthedenovolipogenesispathwayandincidenceoftype2diabetesapooledanalysisofprospectivecohortstudies AT degoedejanette fattyacidsinthedenovolipogenesispathwayandincidenceoftype2diabetesapooledanalysisofprospectivecohortstudies AT gudnasonvilmundur fattyacidsinthedenovolipogenesispathwayandincidenceoftype2diabetesapooledanalysisofprospectivecohortstudies AT harriswilliams fattyacidsinthedenovolipogenesispathwayandincidenceoftype2diabetesapooledanalysisofprospectivecohortstudies AT hodgeallison fattyacidsinthedenovolipogenesispathwayandincidenceoftype2diabetesapooledanalysisofprospectivecohortstudies AT hufrank fattyacidsinthedenovolipogenesispathwayandincidenceoftype2diabetesapooledanalysisofprospectivecohortstudies AT fattyacidsinthedenovolipogenesispathwayandincidenceoftype2diabetesapooledanalysisofprospectivecohortstudies AT koulmanalbert fattyacidsinthedenovolipogenesispathwayandincidenceoftype2diabetesapooledanalysisofprospectivecohortstudies AT laaksomarkku fattyacidsinthedenovolipogenesispathwayandincidenceoftype2diabetesapooledanalysisofprospectivecohortstudies AT lindlars fattyacidsinthedenovolipogenesispathwayandincidenceoftype2diabetesapooledanalysisofprospectivecohortstudies AT linhungju fattyacidsinthedenovolipogenesispathwayandincidenceoftype2diabetesapooledanalysisofprospectivecohortstudies AT mcknightbarbara fattyacidsinthedenovolipogenesispathwayandincidenceoftype2diabetesapooledanalysisofprospectivecohortstudies AT rajaobelinakalina fattyacidsinthedenovolipogenesispathwayandincidenceoftype2diabetesapooledanalysisofprospectivecohortstudies AT riserusulf fattyacidsinthedenovolipogenesispathwayandincidenceoftype2diabetesapooledanalysisofprospectivecohortstudies AT robinsonjenniferg fattyacidsinthedenovolipogenesispathwayandincidenceoftype2diabetesapooledanalysisofprospectivecohortstudies AT samiericecilia fattyacidsinthedenovolipogenesispathwayandincidenceoftype2diabetesapooledanalysisofprospectivecohortstudies AT sennmackenzie fattyacidsinthedenovolipogenesispathwayandincidenceoftype2diabetesapooledanalysisofprospectivecohortstudies AT siscovickdavids fattyacidsinthedenovolipogenesispathwayandincidenceoftype2diabetesapooledanalysisofprospectivecohortstudies AT soedamahmuthusabitas fattyacidsinthedenovolipogenesispathwayandincidenceoftype2diabetesapooledanalysisofprospectivecohortstudies AT sotoodehnianona fattyacidsinthedenovolipogenesispathwayandincidenceoftype2diabetesapooledanalysisofprospectivecohortstudies AT sunqi fattyacidsinthedenovolipogenesispathwayandincidenceoftype2diabetesapooledanalysisofprospectivecohortstudies AT tsaimichaely fattyacidsinthedenovolipogenesispathwayandincidenceoftype2diabetesapooledanalysisofprospectivecohortstudies AT tuomainentomipekka fattyacidsinthedenovolipogenesispathwayandincidenceoftype2diabetesapooledanalysisofprospectivecohortstudies AT uusitupamatti fattyacidsinthedenovolipogenesispathwayandincidenceoftype2diabetesapooledanalysisofprospectivecohortstudies AT wagenknechtlynnee fattyacidsinthedenovolipogenesispathwayandincidenceoftype2diabetesapooledanalysisofprospectivecohortstudies AT warehamnickj fattyacidsinthedenovolipogenesispathwayandincidenceoftype2diabetesapooledanalysisofprospectivecohortstudies AT wujasonhy fattyacidsinthedenovolipogenesispathwayandincidenceoftype2diabetesapooledanalysisofprospectivecohortstudies AT micharenata fattyacidsinthedenovolipogenesispathwayandincidenceoftype2diabetesapooledanalysisofprospectivecohortstudies AT lemaitrerozennn fattyacidsinthedenovolipogenesispathwayandincidenceoftype2diabetesapooledanalysisofprospectivecohortstudies AT mozaffariandariush fattyacidsinthedenovolipogenesispathwayandincidenceoftype2diabetesapooledanalysisofprospectivecohortstudies AT forouhinitag fattyacidsinthedenovolipogenesispathwayandincidenceoftype2diabetesapooledanalysisofprospectivecohortstudies |